Aspect Biosystems - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeAspect Biosystems
Aspect Biosystems logo

Aspect Biosystems

0 followers

About Aspect Biosystems

Aspect Biosystems is a biotechnology company pioneering bioprinted tissue therapeutics with a full-stack platform that combines AI-powered bioprinting, computational design tools, therapeutic cells, and advanced biomaterials to create allogeneic tissue therapeutics. The company focuses on regenerative medicine and developing implantable tissues to replace, repair, or augment biological functions for metabolic and endocrine diseases. Its work spans technology development, therapeutic programs, and partnerships with pharma and biotech leaders to bring tissue-based therapies to the clinic, with a global, collaborative approach.

Recent News

Recent Deals

Key Team Members

Eric Roos

Chief Business Development Officer

Simon Beyer

Chief Technology Officer

Leela Paris

Senior Vice President, Technical Operations

Evert Kroon

VP Translational Sciences

Spiro Getsios

Senior Vice President Of Preclinical R D

Key Facts

HQ Location

Vancouver, Canada

Founded

2013

Employees

51 - 200

Status

Private

Website

https://aspectbiosystems.com